| Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY |
Globe Newswire |
09/01 |
07:01 |
| AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer |
Globe Newswire |
09/01 |
07:00 |
| Auddia Announces Influence Healthcare’s First Specialty Hospital LOI, Marking a Major Milestone in the Company’s Healthcare Expansion |
Globe Newswire |
09/01 |
07:00 |
| NOVONIX Selected for South Korea-U.S. Infrastructure Initiative |
Globe Newswire |
09/01 |
07:00 |
| NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier |
Globe Newswire |
09/01 |
07:00 |
| Yodeck Launches AI Agent for Digital Signage Management |
Globe Newswire |
09/01 |
07:00 |
| Processa Pharmaceuticals to Participate in Upcoming Investor Conferences |
Globe Newswire |
09/01 |
07:00 |
| Aya Gold & Silver to Acquire Copper-Silver Portfolio |
Globe Newswire |
09/01 |
07:00 |
| BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer |
Globe Newswire |
09/01 |
07:00 |
| Lightbridge Receives Notice of Allowance on New Japanese Patent Covering Multi-Zone Fuel Element and 3D Printing Method |
Globe Newswire |
09/01 |
07:00 |
| Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer |
Globe Newswire |
09/01 |
07:00 |
| Remix Therapeutics to Participate in Upcoming Investor Conferences |
Globe Newswire |
09/01 |
07:00 |
| Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses |
Globe Newswire |
09/01 |
07:00 |
| ROC Completes Acquisition of ZTC; Strengthening Competitive Position for ROC’s Vision AI Platform |
Globe Newswire |
09/01 |
07:00 |
| ElevateBio Appoints Steven Falcone as Chief Operating Officer |
Globe Newswire |
09/01 |
07:00 |
| Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences |
Globe Newswire |
09/01 |
07:00 |
| Aquestive Therapeutics to Participate in Upcoming September Investor Conferences |
Globe Newswire |
09/01 |
07:00 |
| Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference |
Globe Newswire |
09/01 |
07:00 |
| Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference |
Globe Newswire |
09/01 |
07:00 |
| RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology |
Globe Newswire |
09/01 |
06:55 |
| YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs |
Globe Newswire |
09/01 |
06:55 |
| Skipio Acquires RapidTalk to Expand AI-Powered Customer Engagement |
Globe Newswire |
09/01 |
06:41 |
| West Susitna Access Road Advances with Geotechnical Drilling and $25 Million Additional Funding Approved |
Globe Newswire |
09/01 |
06:30 |
| Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics |
Globe Newswire |
09/01 |
06:30 |
| Bimergen Energy to Present Their $400 Million Growth Strategy at the Moody Capital Solutions 2026 Conference |
Globe Newswire |
09/01 |
06:30 |
